Profile

Dr. Noah provides coverage of the biotechnology and medical device industries.
He has been an active member of the scientific and financial communities for over 10 years.
Most recently, he worked in the intellectual property department of Diversa Corporation in San Diego.
Previously, he was at Roth Capital Partners in Los Angeles where the healthcare research group provided coverage of companies such as AMGN, AMLN, IDBE, ISIS, and NABI.
He has been published as both a scientist and a management consultant.
Dr. Noah was a post-doctoral fellow at the Salk Institute for Biological Studies, where he studied viral-induced oncogenesis of immune cells.
He received his MBA from San Diego State University while completing his doctoral dissertation in cell signaling at the University of California San Diego School of Medicine.
Dr. Noah holds the Series 7, 63, 86, and 87 registrations.

Former positions of Adam K. Noah

CompaniesPositionEnd
Analyst-Equity 2006-10-29
Analyst-Equity 2005-08-29
See the detail of Adam K. Noah's experience

Training of Adam K. Noah

San Diego State University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adam K. Noah's experience

Connections

18

1st degree connections

3

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies2

Finance

Finance

See company connections